FindTrial
Sign In

Comparison of 2 different doses of Vitamin D to improve bone strength in disease of progressive muscle weakness named DMD.

Comparison of supplementation with two different doses of vitamin D on bone mineral density in patients with Duchenne muscular dystrophy- A randomised double blind control trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019543
Enrollment
48
Registered
2019-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G710- Muscular dystrophy

Interventions

Intervention1: Supplementation with Vitamin D3: Oral Vit D3 4000 units/day for 6 months Control Intervention1: Supplementation with Vitamin D3: Oral Vit D3 1000 units/day for 6 months

Sponsors

Dr Reena Gulati
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with confirmed diagnosis of DMD with serum Vitamin D level < 75 nanomol/L

Exclusion criteria

Exclusion criteria: 1. Patients with other forms of muscular dystrophy 2. Boys with joint contractures and/or severe kyphoscoliosis 3. Inability to stand upright

Design outcomes

Primary

MeasureTime frame
Bone mineral densityTimepoint: 0 months 6 months—

Secondary

MeasureTime frame
Mean change in 6 minute walk distance, time taken to rise from floor, change in Vignos functional scale gradingTimepoint: 0 months 6 months—

Countries

India

Contacts

Public ContactDr S Sasireka

JIPMER, Puducherry

g97rina@gmail.com9443437740

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026